中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共16条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi;  Yu, Chang;  Li, Guangliang;  Wang, Xiaojia;  Shao, Xiying
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report  
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：50/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11
作者:  Zhang, Yanqiang;  Xu, Xiaoqing;  Hu, Can;  Du, Yian;  Ding, Guangyu;  Chen, Jiahui;  Zhu, Xiu;  Xu, Zhiyuan;  Wei, Qing
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Gastric cancer  HER2-positive  conversion therapy  
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis  
Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Fang, Zi-Ru;  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Shao, Xi-Ying;  Wang, Xiaojia
收藏  |  浏览/下载：45/0  |  提交时间：2022/12/23
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang;  Zou, Wei-Bin;  Wang, Xiaojia;  Shao, Xi-Ying
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores 期刊论文
ADVANCED MATERIALS TECHNOLOGIES, 2022
作者:  Hu, Rui;  Lu, Wenlong;  Wei, Guanghao;  Nan, Hexin;  Li, Juan;  Zhao, Qing
收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
solid-state nanopore  single-molecule detection  protein dynamics  monoclonal antibody  protein unfolding  
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang;  Li, Xi-xiang;  Wang, Bei-lei;  Ge, Juan;  Zou, Feng-ming;  Chen, Cheng;  Wang, Jun-jie;  Hu, Chen;  Liu, Jing;  Wang, Wen-chao;  Liu, Qing-song
收藏  |  浏览/下载：103/0  |  提交时间：2022/03/28
HER2  breast cancers  gastric cancers  irreversible inhibitor  drug resistance  
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:  Yang, ZiYan;  Wang, Wei;  Wang, Xiaojia;  Qin, ZhiQuan
收藏  |  浏览/下载：64/0  |  提交时间：2022/01/10
cardiotoxicity  ErbB2  targeting drugs  breast cancer  therapy  
The characteristics and novel clinical implications of CD4+CXCR5+Foxp3+follicular regulatory T cells in breast cancer 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Miao, Xianyuan;  Guo, Qiusheng;  Pan, Zhiwen;  Xu, Xiaohong;  Shao, Xiying;  Wang, Xiaojia
收藏  |  浏览/下载：51/0  |  提交时间：2021/11/01
Breast cancer (BC)  follicular regulatory T cell (Tfr)  T-cell immunoglobulin mucin 3 (TIM-3)